INTRODUCTION Psoriasis is an inflammatory skin condition affecting approximately 2-3% of the United States and world populations.1, 2 It is a systemic inflammatory state that is associated with an increased…

INTRODUCTIONPsoriasis is a chronic, immunologic disease that affects up to 4% of the population.1 The majority of individuals diagnosed with psoriasis have mild or localized disease, affecting less than 3%…

INTRODUCTION Tinea pedis (“athlete’s foot”) is the most common chronic, inflammatory fungal infection.1 It is estimated to be present at any one time in 15-20 percent of the US population,…

INTRODUCTIONRosacea is commonly described as a chronic inflammatory cutaneous disorder, primarily affecting the central facial zone (cheeks, chin, nose and central forehead). It is characterized by various cutaneous symptoms such…

INTRODUCTION Tumor necrosis factor alpha (TNF-alpha) is an inflammatory cytokine involved in the pathogenesis of many inflammatory conditions, including psoriasis. Thus, TNF-alpha inhibitors have been used in the treatment of…

BACKGROUNDNoninvasive procedures with little to no downtime that offer significant improvement to the aging appearance of the skin and underlying musculature are often preferred to surgical procedures. Although no procedure…

CASE REPORT A 63-year-old female with a history of atrial fibrillation presented with an itchy rash of 5 days’ duration. She reported that her cardiologist recently started her on dronaderone…

The Wright State University Department of Dermatology is located in Dayton, OH, and has a rich history of training residents since 1977. The department is composed of four core academic…

Introduction Atopic dermatitis (AD) is characterized by defects in the epidermal barrier and cutaneous inflammation. Moisturizers are the cornerstone of management of AD. However, there is little evidence to recommend…

Daily broad-spectrum sunscreen use is an important intervention to prevent squamous cell carcinoma and invasive melanoma. Now dermatologists can feel confident confirming that it prevents photoaging in middle aged adults…

Phase III Data of Omalizumab and Urticaria Novartis has announced the results of GLACIAL, a Phase III safety registration study in treatment of chronic spontaneous urticaria (CSU) with omalizumab. Omalizumab…

Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the SkinThis phase II trial studies how well capecitabine works in treating patients with advanced or recurrent squamous…